A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder
Y Tu, J Fang, J Cao, Z Wang, J Park, K Jorgenson… - Brain Stimulation, 2018 - Elsevier
Background Major depression is the fourth leading cause of disability worldwide and poses
a socioeconomic burden worldwide. Transcutaneous vagus nerve stimulation (tVNS) is a …
a socioeconomic burden worldwide. Transcutaneous vagus nerve stimulation (tVNS) is a …
[HTML][HTML] Predicting treatment outcome in major depressive disorder using serotonin 4 receptor PET brain imaging, functional MRI, cognitive-, EEG-based, and …
K Köhler-Forsberg, A Jorgensen, VH Dam… - Frontiers in …, 2020 - frontiersin.org
Background Between 30 and 50% of patients with major depressive disorder (MDD) do not
respond sufficiently to antidepressant regimens. The conventional pharmacological …
respond sufficiently to antidepressant regimens. The conventional pharmacological …
An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study
The aim of this study was to investigate if biomarkers in QEEG, genetic and
neuropsychological measures are suitable for the prediction of antidepressant treatment …
neuropsychological measures are suitable for the prediction of antidepressant treatment …
A circadian genomic signature common to ketamine and sleep deprivation in the anterior cingulate cortex
Background Conventional antidepressants usually require several weeks to achieve a full
clinical response in patients with major depressive disorder, an illness associated with …
clinical response in patients with major depressive disorder, an illness associated with …
[HTML][HTML] Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot …
Deep brain stimulation (DBS) of subcallosal cingulate white matter (SCC) may be an
effective approach for treatment-resistant depression (TRD) that otherwise fails to respond to …
effective approach for treatment-resistant depression (TRD) that otherwise fails to respond to …
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression
AS Korb, AM Hunter, IA Cook, AF Leuchter - Clinical Neurophysiology, 2009 - Elsevier
OBJECTIVE: To assess whether pretreatment theta current density in the rostral anterior
cingulate (rACC) and medial orbitofrontal cortex (mOFC) differentiates responders from non …
cingulate (rACC) and medial orbitofrontal cortex (mOFC) differentiates responders from non …
Electroencephalography-derived biomarkers of antidepressant response
DV Iosifescu - Harvard review of psychiatry, 2011 - Taylor & Francis
Recent meta-analyses point to the relatively low efficacy of commonly used antidepressant
medications. Selecting the most effective medications for depressed subjects having failed …
medications. Selecting the most effective medications for depressed subjects having failed …
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
GI Papakostas, M Fava - Dialogues in Clinical Neuroscience, 2008 - Taylor & Francis
Major Depressive Disorder (MDD) is a prevalent illness that is frequently associated with
significant disability, morbidity and mortality. Despite the development and availability of …
significant disability, morbidity and mortality. Despite the development and availability of …
Brainwaves oscillations as a potential biomarker for major depression disorder risk
P Fernández-Palleiro… - Clinical EEG and …, 2020 - journals.sagepub.com
Major depressive disorder (MDD) is a multidimensional disorder that is characterized by the
presence of alterations in mood, cognitive capacity, sensorimotor, and homeostatic …
presence of alterations in mood, cognitive capacity, sensorimotor, and homeostatic …
Reduced early auditory evoked gamma-band response in patients with schizophrenia
BACKGROUND: There is growing evidence for abnormalities of certain γ-aminobutyric acid
(GABA)-ergic interneurons and their interaction with glutamatergic pyramidal cells in …
(GABA)-ergic interneurons and their interaction with glutamatergic pyramidal cells in …